| Los | Titel | Auftragnehmer | Schaetzwert | Vergabewert |
|---|---|---|---|---|
| 1 | Bekanntmachung vergebener Aufträge nach §130 c SGB V zu dem Präparat Ublituximab (Briumvi) | — | 1 |
| Los | Titel | Auftragnehmer | Schaetzwert | Vergabewert |
|---|---|---|---|---|
| 1 | Bekanntmachung vergebener Aufträge nach § 130 a Abs. 8 SGB V und §130 c SGB V zu dem Wirkstoff Tegomil fumarat (Riulvy) | — | 1 |
| Los | Titel | Auftragnehmer | Schaetzwert | Vergabewert |
|---|---|---|---|---|
| 1 | Acetylcystein (OTC) | — | — | — |
| 2 | Acetylcystein (LSE) | — | — | — |
| 3 | Amantadin | — | — | — |
| 4 | Atenolol + Chlortalidon | — | — | — |
| 5 | Baclofen (INF) | — | — | — |
| 6 | Beclometason (DOS) | — | — | — |
| 7 | Beclometason (NAS, NDS, SUV) | — | — | — |
| 8 | Betamethason (CRE) | — | — | — |
| 9 | Betamethason (EMU) | — | — | — |
| 10 | Betamethason (LOE) | — | — | — |
| 11 | Betamethason (SAL) | — | — | — |
| 12 | Bezafibrat (FTA, RET) | — | — | — |
| 13 | Budesonid (DOS) | — | — | — |
| 14 | Budesonid (IHP) | — | — | — |
| 15 | Buprenorphin (PFT; 3 Tage) | — | — | — |
| 16 | Buprenorphin (0,2 mg, 0,4 mg; SUT) | — | — | — |
| 17 | Cabergolin | — | — | — |
| 18 | Calcipotriol + Betamethason (SAL) | — | — | — |
| 19 | Calcipotriol + Betamethason (GEL) | — | — | — |
| 20 | Captopril + Hydrochlorothiazid | — | — | — |
| 21 | Chinin | — | — | — |
| 22 | Ciclopirox (VCR, VSU) | — | — | — |
| 23 | Clobazam (SUE) | — | — | — |
| 24 | Clobazam (TAB) | — | — | — |
| 25 | Clotrimazol Kombipackung | — | — | — |
| 26 | Codein (TAB) | — | — | — |
| 27 | Dexamethason (ATR) | — | — | — |
| 28 | Entacapon | — | — | — |
| 29 | Epinephrin (PEN) | — | — | — |
| 30 | Fentanyl (LUT) | — | — | — |
| 31 | Fesoterodin | — | — | — |
| 32 | Formoterol (6 µg; IHP) | — | — | — |
| 33 | Granisetron (FTA) | — | — | — |
| 34 | Granisetron (IFK) | — | — | — |
| 35 | Ketorolac | — | — | — |
| 36 | Maraviroc (FTA, LSE) | — | — | — |
| 37 | Metamizol (ILO) | — | — | — |
| 38 | Methocarbamol (FTA, IIL) | — | — | — |
| 39 | Moclobemid | — | — | — |
| 40 | Mometason furoat (CRE) | — | — | — |
| 41 | Mometason furoat (LOE) | — | — | — |
| 42 | Mometason furoat (SAL) | — | — | — |
| 43 | Naltrexon | — | — | — |
| 44 | Nifedipin (RET) | — | — | — |
| 45 | Sulpirid (HKP, TAB) | — | — | — |
| 46 | Tacrolimus (Prograf, Advagraf) | — | — | — |
| 47 | Terazosin | — | — | — |
| 48 | Testosteron (180 mg; ILO) | — | — | — |
| 49 | Tiaprid | — | — | — |
| 50 | Tizanidin | — | — | — |
| 51 | Tolperison | — | — | — |
| 52 | Triacylglycerollipase (40.000 PhEur.-E.) | — | — | — |
| Los | Titel | Auftragnehmer | Schaetzwert | Vergabewert |
|---|---|---|---|---|
| 1 | Acarbose | — | — | — |
| 2 | Atenolol | — | — | — |
| 3 | Baclofen (TAB) | — | — | — |
| 4 | Bimatoprost (0,1 mg; 0,12 mg) | — | — | — |
| 5 | Bosutinib | — | — | — |
| 6 | Brinzolamid + Brimonidin | — | — | — |
| 7 | Budesonid (SUV) | — | — | — |
| 8 | Buprenorphin (PFT; 7 Tage) | — | — | — |
| 9 | Cetirizin (LSE, SAF, LOE, TRO) | — | — | — |
| 10 | Ciclopirox (CRE, LOE) | — | — | — |
| 11 | Cyproteron + Ethinylestradiol | — | — | — |
| 12 | Ebastin (FTA) | — | — | — |
| 13 | Eisencarboxymaltose (IID) | — | — | — |
| 14 | Fluoxetin (20 mg) | — | — | — |
| 15 | Formoterol (12 µg; HPI) | — | — | — |
| 16 | Formoterol (12 µg; IHP) | — | — | — |
| 17 | Formoterol (12,5 µg: HPI) | — | — | — |
| 18 | Ginkgoblätter Trockenextrakt (FTA) | — | — | — |
| 19 | Hydromorphon (AMP, IIL, ILO) | — | — | — |
| 20 | Isotretinoin | — | — | — |
| 21 | Lactulose (SIR) | — | — | — |
| 22 | Lansoprazol | — | — | — |
| 23 | Loperamid (RX) | — | — | — |
| 24 | Loperamid (OTC) | — | — | — |
| 25 | Loratadin | — | — | — |
| 26 | Memantin (LSE) | — | — | — |
| 27 | Methocarbamol (750 mg) | — | — | — |
| 28 | Methocarbamol (1500 mg) | — | — | — |
| 29 | Methylphenidat (RET; 30 St) | — | — | — |
| 30 | Nilotinib | — | — | — |
| 31 | Propranolol (10 mg) | — | — | — |
| 32 | Ramipril + Amlodipin | — | — | — |
| 33 | Risedronsäure | — | — | — |
| 34 | Sulfasalazin | — | — | — |
| 35 | Tacrolimus (SAL) | — | — | — |
| 36 | Triacylglycerollipase (20.000 PhEur.-E.) | — | — | — |
| 37 | Triacylglycerollipase (25.000 PhEur.-E.) | — | — | — |
| 38 | Triamcinolon acetonid (CRE) | — | — | — |
| 39 | Acetylsalicylsäure (100 mg; OTC) | — | — | — |
| 40 | Aprepitant (HKP) | — | — | — |
| 41 | Atomoxetin (HKP) | — | — | — |
| 42 | Bimatoprost (0,3 mg) | — | — | — |
| 43 | Bosentan | — | — | — |
| 44 | Brimonidin (ATR, EDP) | — | — | — |
| 45 | Buprenorphin (PFT; 4 Tage) | — | — | — |
| 46 | Buprenorphin (0,4 mg, 2 mg, 8 mg; SUT) | — | — | — |
| 47 | Cetirizin (FTA) | — | — | — |
| 48 | Dasatinib | — | — | — |
| 49 | Dimethylfumarat | — | — | — |
| 50 | Emtricitabin + Tenofovir disoproxil | — | — | — |
| 51 | Enalapril + Lercanidipin | — | — | — |
| 52 | Entecavir | — | — | — |
| 53 | Etoricoxib | — | — | — |
| 54 | Exemestan | — | — | — |
| 55 | Febuxostat | — | — | — |
| 56 | Flecainid | — | — | — |
| 57 | Hydromorphon (REK, RET) | — | — | — |
| 58 | Hydromorphon (HKP) | — | — | — |
| 59 | Irbesartan + Hydrochlorothiazid | — | — | — |
| 60 | Letrozol | — | — | — |
| 61 | Levetiracetam (FTA) | — | — | — |
| 62 | Levetiracetam (IFK) | — | — | — |
| 63 | Levocetirizin (OTC) | — | — | — |
| 64 | Mometason furoat (NAS, NDS) | — | — | — |
| 65 | Olanzapin (FTA, SMT, TAB, UTA) | — | — | — |
| 66 | Pirfenidon (FTA) | — | — | — |
| 67 | Pomalidomid | — | — | — |
| 68 | Rasagilin | — | — | — |
| 69 | Rivaroxaban | — | — | — |
| 70 | Solifenacin | — | — | — |
| 71 | Tenofovir disoproxil | — | — | — |
| 72 | Testosteron (1000 mg; ILO) | — | — | — |
| 73 | Travoprost | — | — | — |
| 74 | Valsartan | — | — | — |
| 75 | Valsartan + Hydrochlorothiazid | — | — | — |
| Los | Titel | Auftragnehmer | Schaetzwert | Vergabewert |
|---|---|---|---|---|
| 1 | Lamotrigin 25 mg Tablette zur Herstellung einer Suspension zum Einnehmen St | — | — | |
| 2 | Levomethadon hydrochlorid 5 mg in 1 ml Tropfen Tropfen zum Einnehmen St a 20 ml | — | — | |
| 3 | Pramipexol 0,26 mg Retard-Tabletten St | — | — | |
| 4 | Pramipexol 0,52 mg Retard-Tabletten St | — | — | |
| 5 | Pramipexol 1,57 mg Retard-Tabletten St | — | — | |
| 6 | Pramipexol 2,62 mg Retard-Tabletten St | — | — | |
| 7 | Pramipexol 3,15 mg Retard-Tabletten St | — | — | |
| 8 | Trimipramin 100 mg Tabletten St | — | — | |
| 9 | Trimipramin 25 mg Tabletten St | — | — |
| Los | Titel | Auftragnehmer | Schaetzwert | Vergabewert |
|---|---|---|---|---|
| 1 | Lamotrigin 100 mg Tablette zur Herstellung einer Suspension zum Einnehmen St | — | — | |
| 2 | Levodopa 100 mg, Benserazid 25 mg Hartkapseln o. Tabletten St | — | — | |
| 3 | Levodopa 50 mg, Benserazid 12,5 mg Hartkapseln o. Tabletten St | — | — | |
| 4 | Pipamperon 20 mg in 5 ml Saft Lösung zum Einnehmen St a 200 ml | — | — |
| Los | Titel | Auftragnehmer | Schaetzwert | Vergabewert |
|---|---|---|---|---|
| 1 | Methylphenidat 23,35 mg, entspricht Methylphenidat hydrochlorid 27,00 mg Tabletten differenzierte Freisetzung St | — | — | |
| 2 | Methylphenidat 31,13 mg, entspricht Methylphenidat hydrochlorid 36,00 mg Tabletten differenzierte Freisetzung St | — | — |
| Los | Titel | Auftragnehmer | Schaetzwert | Vergabewert |
|---|---|---|---|---|
| 1 | Bupropion hydrochlorid 150 mg Tablette mit veränderter Wirkstofffreisetzung St | — | — | |
| 2 | Opipramol dihydrochlorid 50 mg Filmtabletten St | — | — | |
| 3 | Rotigotin 1 mg/d Pflaster transdermal konstante Freisetzung St | — | — | |
| 4 | Rotigotin 2 mg/d Pflaster transdermal konstante Freisetzung St | — | — | |
| 5 | Rotigotin 3 mg/d Pflaster transdermal konstante Freisetzung St | — | — | |
| 6 | Rotigotin 4 mg/d Pflaster transdermal konstante Freisetzung St | — | — | |
| 7 | Rotigotin 6 mg/d Pflaster transdermal konstante Freisetzung St | — | — | |
| 8 | Rotigotin 8 mg/d Pflaster transdermal konstante Freisetzung St | — | — |
| Los | Titel | Auftragnehmer | Schaetzwert | Vergabewert |
|---|---|---|---|---|
| 1 | Ublituximab 150 mg in 6 ml Konzentrat Infusionslösungskonzentrat St | — | — |